AKT1 and early-onset autosomal dominant Alzheimer disease: However, GSI treatment will also cause a side effect in healthy cells in Alzheimer’s disease patients since GSI will prevent the normal processing of Notch, whose cleavage by GS at plasma membrane generates ICN, a PTEN suppressor and an Akt enhancer, promoting cell survival [41], [42].